Development of a Smart Scaffold for Sequential Cancer Chemotherapy and Tissue Engineering.
Journal
ACS omega
ISSN: 2470-1343
Titre abrégé: ACS Omega
Pays: United States
ID NLM: 101691658
Informations de publication
Date de publication:
25 Aug 2020
25 Aug 2020
Historique:
received:
01
11
2019
accepted:
26
05
2020
entrez:
3
9
2020
pubmed:
3
9
2020
medline:
3
9
2020
Statut:
epublish
Résumé
The fabrication of a dual-functional drug-containing porous polymeric scaffold by layer-by-layer surface modification involving citrate-stabilized gold nanoparticles and cisplatin molecules is being reported. These scaffolds were characterized by electron microscopy and X-ray photoelectron spectroscopy. The capability of the scaffolds to release hydrated cisplatin in a slow and sustained manner over two days is established. Most importantly, the scaffolds turn nontoxic and cell-friendly after drug release, thus allowing the noncancerous fibroblast cells to adhere and proliferate (from 5000 cells to 16,000 cells in 6 days), becoming a potential solution toward an effective drug-carrying scaffold for volume-filling applications. The scaffold-mediated cancer cell killing and fibroblast cell proliferation were confirmed by fluorescence microscopy imaging, flow cytometry, and cell proliferation assays. We surmise that such a dual-purpose (drug-delivery and volume-filler) scaffold could help avoid the multiple surgical interventions needed for tumor surgery and cosmetic corrections. To the best of our knowledge, this is the first example of scaffolds with such a dual functionality which gets manifested in a sequential manner.
Identifiants
pubmed: 32875205
doi: 10.1021/acsomega.9b03694
pmc: PMC7450502
doi:
Types de publication
Journal Article
Langues
eng
Pagination
20724-20733Informations de copyright
Copyright © 2020 American Chemical Society.
Déclaration de conflit d'intérêts
The authors declare no competing financial interest.
Références
Plast Surg (Oakv). 2014 Spring;22(1):14-7
pubmed: 25152641
Talanta. 1973 Feb;20(2):199-210
pubmed: 18961255
N Engl J Med. 2007 Oct 25;357(17):1695-704
pubmed: 17960012
J Ophthalmol. 2015;2015:904096
pubmed: 26689343
Scand J Plast Reconstr Surg Hand Surg. 2000 Mar;34(1):9-14
pubmed: 10756570
Br J Cancer. 1995 Apr;71(4):676-83
pubmed: 7710928
Oral Oncol. 2009 Apr-May;45(4-5):394-401
pubmed: 18674952
Expert Opin Drug Deliv. 2009 Oct;6(10):1017-32
pubmed: 19732031
Int J Nanomedicine. 2018 Mar 15;13(T-NANO 2014 Abstracts):87-90
pubmed: 29593403
Pharmacol Rev. 2012 Jul;64(3):706-21
pubmed: 22659329
Int J Mol Sci. 2017 Dec 21;19(1):
pubmed: 29267207
Chem Biol. 2004 Apr;11(4):557-64
pubmed: 15123250
Cytotechnology. 2016 May;68(3):355-69
pubmed: 26091616
J Plast Reconstr Aesthet Surg. 2010 Oct;63(10):1615-23
pubmed: 19577527
J Maxillofac Oral Surg. 2014 Mar;13(1):42-6
pubmed: 24644395
ACS Appl Mater Interfaces. 2018 Sep 19;10(37):30936-30945
pubmed: 30148349
Proc Natl Acad Sci U S A. 2010 Jul 13;107(28):12435-40
pubmed: 20616005
Proc Natl Acad Sci U S A. 2008 Nov 11;105(45):17356-61
pubmed: 18978032
Indian J Plast Surg. 2010 Jan;43(1):34-9
pubmed: 20924447
ACS Omega. 2018 Apr 30;3(4):4242-4251
pubmed: 30023888